Cognition Kit DSST App Validated for Measuring Major Depressive Disorder
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
For insights on the effect of more vigilant personal hand hygiene and guidance on how best to maintain these practices while addressing concerns about skin disorders, we spoke with Joel Schlessinger, MD, a board-certified dermatologic surgeon.
If approved, HP-3070 would be the first transdermal antipsychotic available in the United States, and would provide a novel, safe, and efficacious treatment delivery system for adult patients with schizophrenia.